Professor Aled Clayton
Projects as PI
- Cancer exosomes as drivers of disease progression, targeting exosome biogenesis to halt disease progression (01/01/2014 - 31/12/2016)
- Cancer exosomes control tumour reactive stroma in malignant pleural mesothelioma (01/11/2009 - 31/10/2010)
- Characterising exosome uptake for elucidating their role in cancer progression and as potential drug delivery vectors (01/10/2015 - 01/12/2018)
- Combination treatment modelling for personalised immunotherapy in mesothelioma (01/03/2018 - 31/07/2021)
- Development of the Zetaview instrument (15/05/2016 - 14/08/2016)
Projects as Co-Investigator
- An acoustic chip for separating circulating tumour biomarkers for cancer diagnosis and treatment monitoring (01/02/2018 - 31/01/2019)
- Combination treatment modelling for personalised immunotherapy in mesothelioma (01/03/2018 - 31/07/2021)
- Comparative Health Research Outcomes of NOvel Surgery in prostate cancer - IP4 Chronos (01/10/2019 - 30/04/2022)
- Developing a blood-based assay for predicting response to immune checkpoint inhibition in cancer patients (01/01/2020 - 01/03/2023)
- Development of a nanoscale, near-infrared spectroscopy imaging tool for in situ, rapid and label-free analysis of single extracellular vesicles (01/04/2023 - 31/03/2024)